Cargando…

SAT519 Association of Free Thyroxine Level With Survival Outcome In Patients With Intermediate And High-Risk Differentiated Thyroid Cancer

Disclosure: R. Ghosh: None. S. Auh: None. S. Gubbi: None. P. Veeraraghavan: None. C. Cochran: None. L. Shobab: None. K.D. Burman: None. L. Wartofsky: None. J. Klubo-Gwiezdzinska: None. Background Total thyroidectomy followed by radioiodine (RAI) is a standard treatment for patients with intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Raisa, Auh, Sungyoung, Gubbi, Sriram, Veeraraghavan, Padmasree, Cochran, Craig, Shobab, Leila, Burman, Kenneth D, Wartofsky, Leonard, Klubo-Gwiezdzinska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553418/ http://dx.doi.org/10.1210/jendso/bvad114.1991

Ejemplares similares

SAT561 Pathogenic RET V804M Germline Variant Without Clinical Manifestations Of Multiple Endocrine Neoplasia Type 2 In An Elderly Male
por: Ghosh, Raisa, et al.
Publicado: (2023)

FRI476 Asymptomatic Thyrotropin-secreting Pituitary Microadenoma With Biochemical Secondary Hyperthyroidism: A Diagnostic Conundrum
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

SAT521 Predictive Value of Tumor Volumetrics in Patients with Medullary Thyroid Cancer
por: Behairy, Noha, et al.
Publicado: (2023)

SAT559 Challenges Involved in Managing a Paraplegic Patient with Metastatic Papillary Thyroid Cancer Requiring Radioactive Iodine Therapy
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

SAT556 An Unusual Case of Papillary Thyroid Carcinoma With Biallelic MEN1 Variants In a Patient With MEN1
por: Chuki, Elias, et al.
Publicado: (2023)

A Unique Presentation of Metastatic Follicular Thyroid Cancer Associated with Hyperthyroidism and an Active Graves’ Orbitopathy
por: Al-Jundi, Mohammad, et al.
Publicado: (2021)

SAT562 Metastatic Oncocytic (Formerly Hürthle Cell) Thyroid Carcinoma in a Patient With Birt-Hogg-Dubé Syndrome
por: Vaid, Sonal, et al.
Publicado: (2023)

MON-556 Sex-Bias in Clinicopathological Presentation of Patients with Differentiated Thyroid Cancer
por: Shobab, Leila, et al.
Publicado: (2019)

OR27-3 A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology: A Pilot Cohort Study
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

SAT555 Utility of (18)F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B
por: Varghese, Diana Grace, et al.
Publicado: (2023)

PSAT387 An Unusual Case of Sporadic Metastatic Medullary Thyroid Cancer Without a Primary Tumor Presenting with Paraneoplastic Cushing's Syndrome
por: Jumani, Sanjay, et al.
Publicado: (2022)

SAT-502 Clinical Hypothyroidism Associated with Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma: A Novel Adverse Effect of Peptide Receptor Radionuclide Therapy
por: Gubbi, Sriram, et al.
Publicado: (2020)

SAT-519 Armour Thyroid and Liothyronine Combination Potentiated Thrombosis
por: Shin, Tai Ho, et al.
Publicado: (2020)

SUN-553 Atypical Spindle Cells on a Thyroid Aspirate: A Rare Case of a Thyroid Schwannoma Presenting as a Progressively Expanding Thyroid Nodule
por: Gubbi, Sriram, et al.
Publicado: (2019)

Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2019)

SAT-553 Gut Microbiota Involved in Thyroxine Metabolism and Development of Subclinical Hypothyroidism
por: Bo, Tao, et al.
Publicado: (2019)

OR09-5 mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

SAT-575 Radiolabeled Somatostatin Receptor Analog (86)Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 in Thyroid Cancer Mice Models
por: Thakur, Shilpa, et al.
Publicado: (2019)

SUN-519 Hypokalemic Periodic Paralysis
por: Godfrey, Sean, et al.
Publicado: (2020)

OR19-4 High Prevalence of Primary Hypothyroidism in Patients with Alkaptonuria Eighteen Years of Experience
por: Avadhanula, Shirisha, et al.
Publicado: (2019)

OR09-3 Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

SAT-505 Non-Adherence to Levothyroxine Treatment, a Condition Not to Be Ignored nor Forgotten, Should Be Assessed by Thyroxine Absorption Test
por: Effraimidis, Grigorios, et al.
Publicado: (2020)

ODP519 Thyroid Cyst Grows E. coli
por: Hayes, Clarissa, et al.
Publicado: (2022)

Evaluation of the Optimal Thyroxine Levels for Thyroxine Hormone Replacement in Patients With Central Hypothyroidism
por: Lee, Ka Fai, et al.
Publicado: (2021)

FRI519 Misleading Free T4 Due To Assay Interference
por: Man Pradhan, Rubin, et al.
Publicado: (2023)

Levothyroxine Treatment in Pregnancy: Indications, Efficacy, and Therapeutic Regimen
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011)

Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2020)

RF23 | PSAT365 An Open-Label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
por: Sachmechi, Issac, et al.
Publicado: (2022)

MON-563 Quantitative Assessment Of BRAF Mutations In Thyroid Cancer Using Droplet Digital PCR.
por: Ylli, Dorina, et al.
Publicado: (2019)

MON-611 Biux2x2
por: Kushchayeva, Yevgeniya, et al.
Publicado: (2019)

MON-551 Immediate Cause Of Death In Patients With Thyroid Cancer Progression
por: Ylli, Dorina, et al.
Publicado: (2019)

THYROID EMERGENCIES
por: Ylli, Dorina, et al.
Publicado: (2019)

SUN-560 Thyrotoxic Hashimoto's Disease: Is It Graves' Thyrotoxicosis or "Hashitoxicosis"?
por: Baral, Neelam, et al.
Publicado: (2019)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

MON-514 Detection of RAS Mutations and RET/PTC Fusions in Thyroid Cancer Using Microfluidic Digital PCR
por: Ylli, Dorina, et al.
Publicado: (2020)

MON-519 In Silico Analysis of rs1042522 and rs1042522 Polymorphic Variants of TP53 Gene
por: Bó, Izabela Dal, et al.
Publicado: (2020)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
por: Luo, Hongxiu, et al.
Publicado: (2022)

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study
por: Aswath, Kshama, et al.
Publicado: (2021)

ODP511 Relationship between TSH and Free Thyroxine in Outpatient Cancer Patient Population
por: Li, Jieli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6tsmdfcr9bq79d2f94hun1bbd